ICaPath is a biotech startup that engages in nanoparticle immunotherapy and immunodiagnostics.
ICaPath has raised $650K in total funding. The most recent round was Seed. The last funding was announced in September 2022.
ICaPath is headquartered in Morgantown, United States.
ICaPath is a biotech startup that engages in nanoparticle immunotherapy and immunodiagnostics.
ICaPath is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ICaPath — Funding & Investors." VCBacked, September 15, 2022, https://www.vcbacked.co/company/icapath. Accessed August 14, 2026.
VCBacked. (2022). ICaPath — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/icapath
{{cite web |title=ICaPath — Funding & Investors |url=https://www.vcbacked.co/company/icapath |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated